Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Gene Therapy to Activate CXCR4 for HIV by Sangamo Therapeutics for Human Immunodeficiency Virus (HIV) Infections (AIDS): Likelihood of Approval
Gene Therapy to Activate CXCR4 for HIV is under clinical development by Sangamo Therapeutics and currently in Phase I for...